Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema

被引：0
作者：
Yen-Yi Chen
Pei-Ying Chen
Fang-Ting Chen
Yun-Ju Chen
Jia-Kang Wang
机构：
[1] Far Eastern Memorial Hospital,Department of Ophthalmology
[2] Fu Jen Catholic University,Department of Medicine
[3] National Taiwan University,Department of Medicine
[4] National Yang Ming University,Department of Medicine
[5] Yuan Ze University,Department of Electrical Engineering
[6] Oriental Institute of Technology,Department of Healthcare Administration and Department of Nursing
来源：
International Ophthalmology | 2018年 / 38卷
关键词：
Intravitreal injection; Diabetic macular edema; Ranibizumab; Vitrectomized eyes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 299
页数：6
相关论文
共 50 条
[21]   Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes [J].
Coelho, Joao ;
Malheiro, Luisa ;
Beirao, Joao Melo ;
Meireles, Angelina ;
Pessoa, Bernardete .
CLINICAL OPHTHALMOLOGY, 2019, 13 :1751-1759
[22]   One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes [J].
Liang, Youling ;
Yan, Bin ;
Xie, Manyun ;
Meng, Zhishang ;
Ma, Jiayue ;
Ma, Bosheng ;
Luo, Jing .
FRONTIERS IN MEDICINE, 2022, 9
[23]   Comparison of Modified Grid Laser & Intravitreal Ranibizumab, and Mild Macular Laser & Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema [J].
Guzey, Mustafa ;
Adibelli, Fatih Mehmet ;
Altun, Gonul .
OPHTHALMOLOGICA, 2014, 232 :14-15
[24]   Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye [J].
Aoki, Ren ;
Hatano, Makoto ;
Higashijima, Fumiaki ;
Yoshimoto, Takuya ;
Mikuni, Masanori ;
Ogata, Tadahiko ;
Kobayashi, Yuka ;
Wakuta, Makiko ;
Kimura, Kazuhiro .
CASE REPORTS IN OPHTHALMOLOGY, 2021, 12 (03) :841-847
[25]   Treatment of macular edema in diabetic retinopathy: comparison of the efficacy of intravitreal bevacizumab and ranibizumab injections [J].
Ekinci, Metin ;
Ceylan, Erdinc ;
Cakici, Ozgur ;
Tanyildiz, Burak ;
Olcaysu, Okan ;
Cagatay, Halil Huseyin .
EXPERT REVIEW OF OPHTHALMOLOGY, 2014, 9 (02) :139-143
[26]   Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema [J].
Gabr, Ahmed F. ;
Kamel, Marian F. ;
Elbarawy, Ahmed A. .
INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (09) :3219-3226
[27]   Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema [J].
Ahmed F. Gabr ;
Marian F. Kamel ;
Ahmed A. Elbarawy .
International Ophthalmology, 2023, 43 :3219-3226
[28]   Early Retinal Vascular Caliper Changes After Intravitreal Ranibizumab in Eyes with Diabetic Macular Edema [J].
Aslankurt, Murat ;
Kurt, Muhammet Mustafa ;
Cekic, Osman ;
Erden, Burak ;
Akpolat, Cetin ;
Elcioglu, Mustafa .
OPHTHALMOLOGICA, 2014, 232 :63-63
[29]   Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema [J].
Douvali, Maria ;
Chatziralli, Irini P. ;
Theodossiadis, Panagiotis G. ;
Chatzistefanou, Klio I. ;
Giannakaki, Emmanouella ;
Rouvas, Alexandros A. .
OPHTHALMOLOGICA, 2014, 232 (03) :136-143
[30]   A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes [J].
Raquel Estebainha ;
Raquel Goldhardt ;
Manuel Falcão .
Current Ophthalmology Reports, 2020, 8 :1-10
12345